Quarterly report pursuant to Section 13 or 15(d)

Notes Payable and Long-Term Debt (Details Narrative)

v3.21.1
Notes Payable and Long-Term Debt (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 05, 2021
USD ($)
$ / shares
shares
Dec. 14, 2020
USD ($)
$ / shares
shares
Aug. 07, 2020
USD ($)
$ / shares
shares
Aug. 05, 2020
USD ($)
shares
Apr. 01, 2020
USD ($)
shares
Mar. 05, 2020
USD ($)
$ / shares
shares
Feb. 06, 2020
USD ($)
shares
Feb. 06, 2020
USD ($)
shares
Jan. 30, 2020
USD ($)
shares
Jul. 20, 2020
USD ($)
$ / shares
shares
May 29, 2020
USD ($)
$ / shares
shares
Apr. 30, 2020
USD ($)
$ / shares
shares
Feb. 29, 2020
USD ($)
Mar. 31, 2021
USD ($)
$ / shares
shares
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Amortization of debt discount                           $ 704,223 $ 313,297  
Debt instrument, maturity date                           Apr. 24, 2021    
Warrant exercise price per share | $ / shares                              
Securities Purchase Agreement and Note [Member] | Two Accredited Investors [Member]                                
Debt discount, amount             $ 32,000 $ 32,000                
Aggregate purchase price             $ 400,000                  
Number of common stock issued | shares             600,000                  
Debt instrument face amount             $ 432,000 $ 432,000                
Securities Purchase Agreement and Note [Member] | Accredited Investors Two [Member]                                
Debt discount, amount   $ 48,600               $ 145,538         $ 241,200  
Aggregate purchase price         $ 150,000                      
Issuance of common stock to investor | shares         172,000                      
Number of common stock issued | shares               300,000                
Debt instrument, maturity date         Mar. 15, 2021     Apr. 05, 2021                
Debt instrument face amount         $ 162,000                      
Exchange of common stock | shares               225,000                
Fair value of grant shares               $ 28,965   $ 42,362            
Common stock conversion price | $ / shares                   $ 0.70            
Debt discount price                   0.30            
Fair value of grant shares, shares | shares   300,000               270,000            
Debt instrument, interest per annum                             14.00%  
Exercise warrant shares | shares   150,000                            
Warrant exercise price per share | $ / shares   $ 0.40                            
Securities Purchase Agreement and Note [Member] | Accredited Investors [Member]                                
Debt discount, amount                   $ 62,100            
Exercise warrant shares | shares                   338,000            
Warrant exercise price per share | $ / shares                   $ 0.40            
Promissory Note [Member]                                
Restricted shares of common stock granted | shares                           100,000    
Debt discount, amount                           $ 0   $ 0
Amortization of debt discount                           31,200    
January 2020 Notes [Member]                                
Debt discount, amount     $ 260,001           $ 40,000       $ 214,000 0    
Amortization of debt discount                           $ 52,257    
Aggregate purchase price                 $ 500,000              
Issuance of common stock to investor | shares                 250,000              
Number of common stock issued | shares     750,000           750,000              
Debt instrument, maturity date     Apr. 05, 2021                          
Debt instrument face amount                 $ 540,000              
Exchange of common stock | shares     195,000                          
Fair value of grant shares     $ 30,225                   600,000      
Common stock conversion price | $ / shares     $ 0.65                          
Debt discount price     0.35                          
Shares issued for conversion of debt, shares | shares                           1,100,555    
Long term notes payable                           $ 177,908    
February 2020 Notes [Member]                                
Debt discount, amount       $ 186,000     32,000 32,000               389,342
Aggregate purchase price             $ 400,000                  
Issuance of common stock to investor | shares             300,000                  
Number of common stock issued | shares             600,000                  
Debt instrument, maturity date             Apr. 05, 2021                  
Debt instrument face amount             $ 432,000 $ 432,000                
Exchange of common stock | shares       225,000     600,000                  
Fair value of grant shares       $ 28,695                        
the January 2020 Notes | Securities Purchase Agreements [Member]                                
Debt discount, amount                         $ 186,000      
the February 2020 Notes [Member] | Securities Purchase Agreements [Member]                                
Debt discount, amount                           0    
Amortization of debt discount                           42,658    
Long term notes payable                           0    
the March 2020 Notes [Member] | Securities Purchase Agreements [Member]                                
Debt discount, amount           $ 28,000               0    
Amortization of debt discount                           47,018    
Aggregate purchase price           $ 350,000                    
Number of common stock issued | shares           400,000                    
Debt instrument, maturity date           Apr. 05, 2021                    
Debt instrument face amount           $ 378,000                    
Common stock conversion price | $ / shares           $ 0.65                    
Long term notes payable                           0    
Fair value of grant shares, shares | shares           400,000                    
Debt instrument, interest per annum           35.00%                    
the April 2020 SPA [Member] | Securities Purchase Agreement and Note [Member] | Accredited Investors Two [Member]                                
Debt discount, amount                       $ 103,560   0    
Amortization of debt discount                           32,843    
Fair value of grant shares                       $ 46,400        
Common stock conversion price | $ / shares                       $ 0.65        
Long term notes payable                           0    
Fair value of grant shares, shares | shares                       172,000        
Debt instrument, interest per annum                       35.00%        
the May 2020 SPA [Member] | Securities Purchase Agreement and Note [Member] | Accredited Investors Two [Member]                                
Debt discount, amount                           0    
Amortization of debt discount                               $ 80,000
Aggregate purchase price                     $ 370,000          
Issuance of common stock to investor | shares                     400,000          
Number of common stock issued | shares                     500,000          
Debt instrument face amount                     $ 400,000          
Fair value of grant shares                     $ 96,396          
Common stock conversion price | $ / shares                     $ 0.65          
Long term notes payable                           0    
Fair value of grant shares, shares | shares                     400,000          
Debt instrument, interest per annum                     10.00%          
Exercise warrant shares | shares                     500,000          
Warrant exercise price per share | $ / shares                     $ 0.40          
the July 2020 SPA [Member] | Securities Purchase Agreement and Note [Member] | Accredited Investors Two [Member]                                
Aggregate purchase price                   $ 250,000            
Issuance of common stock to investor | shares                   270,000            
Debt instrument face amount                   $ 270,000            
Debt instrument, interest per annum                   10.00%            
the July 2020 SPA [Member] | Securities Purchase Agreements [Member]                                
Debt discount, amount                           19,708    
Amortization of debt discount                           88,686    
the December 2020 SPA [Member]                                
Debt discount, amount                           99,611    
Amortization of debt discount                           55,000    
Fair value of grant shares                           39,082    
the December 2020 SPA [Member] | Securities Purchase Agreement and Note [Member] | Accredited Investors Two [Member]                                
Debt discount, amount   $ 77,318                            
Aggregate purchase price   $ 153,000                            
Issuance of common stock to investor | shares   300,000                            
Number of common stock issued | shares   150,000                            
Debt instrument, maturity date   Sep. 14, 2021                            
Debt instrument face amount   $ 165,000                            
Common stock conversion price | $ / shares   $ 0.70                            
Debt discount price   0.30                            
Debt instrument, interest per annum   10.00%                            
January 2021 SPA [Member] | January 2021 Investor [Member]                                
Debt discount, amount $ 77,318                         0    
Amortization of debt discount                           160,829    
Aggregate purchase price $ 230,000                              
Issuance of common stock to investor | shares 900,000                              
Number of common stock issued | shares 460,000                              
Debt instrument, maturity date May 05, 2021                              
Debt instrument face amount $ 250,000                              
Common stock conversion price | $ / shares $ 0.70                              
Debt discount price 0.10                              
Long term notes payable                           $ 0    
Fair value of grant shares, shares | shares 900,000                              
Debt instrument, interest per annum 10.00%                              
Exercise warrant shares | shares 460,000                              
Warrant term 3 years                              
Debt fair value $ 97,200                              
Warrant maturity date Jan. 04, 2025                              
Warrant fair value $ 43,629